LifeStance Health Group Inc（LFST）财务数据LFSTLifeStance Health Group Inc

Evaluating the bottom line, LifeStance Health Group, Inc. maintains a gross margin of 100.00%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 7.29%, while the net margin is 5.42%. These profitability ratios, combined with a Return on Equity (ROE) of 3.43%, provide a clear picture of how effectively LFST converts its operational activities into shareholder value.

In the context of the broader market, LFST competes directly with industry leaders such as BLLN and CON. With a market capitalization of $4.75B, it holds a leading position in the sector. When comparing efficiency, LFST's gross margin of 100.00% stands against BLLN's 70.45% and CON's 28.41%. Such benchmarking helps identify whether LifeStance Health Group, Inc. is trading at a premium or discount relative to its financial performance.

LifeStance has shown significant financial improvement, with Q2 2026 revenue of $435.4 million and an adjusted EBITDA margin of 15.2%. The company also raised its full-year revenue guidance to $1.71 billion, reflecting confidence in continued growth.